David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Room 43-229 CHS, Los Angeles, CA 90095, USA.
David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Avenue, Room 43-229 CHS, Los Angeles, CA 90095, USA.
Crit Care Clin. 2022 Jul;38(3):455-472. doi: 10.1016/j.ccc.2022.01.001. Epub 2022 Jan 10.
With an ever-increasing number of COVID-19 survivors, providers are tasked with addressing the longer lasting symptoms of COVID-19, or postacute sequelae of SARS-CoV-2 infection (PASC). For critically ill patients, existing knowledge about postintensive care syndrome (PICS) represents a useful structure for understanding PASC. Post-ICU clinics leverage a multidisciplinary team to evaluate and treat the physical, cognitive, and psychological sequelae central to both PICS and PASC in critically ill patients. While management through both pharmacologic and nonpharmacologic modalities can be used, further research into both the optimal treatment and prevention of PASC represents a key public health imperative.
随着 COVID-19 幸存者人数的不断增加,医护人员的任务是解决 COVID-19 的持续时间较长的症状,或 SARS-CoV-2 感染的后遗症(PASC)。对于重症患者,关于重症监护后综合征(PICS)的现有知识为理解 PASC 提供了一个有用的结构。重症监护后诊所利用多学科团队来评估和治疗重症患者中与 PICS 和 PASC 都相关的身体、认知和心理后遗症。虽然可以使用药物和非药物治疗模式进行管理,但进一步研究 PASC 的最佳治疗和预防方法代表了一个关键的公共卫生要务。